Cargando…
Clinical predictors of NEDA-3 one year after diagnosis of pediatric multiple sclerosis: an exploratory single-center study
INTRODUCTION: Multiple sclerosis (MS) is an inflammatory and demyelinating disorder of central nervous system that can be diagnosed in pediatric age (<18 years) in 3–5% of the cases. This early onset is associated with higher relapse rates and earlier progression to neurological disability. By us...
Autores principales: | Palavra, Filipe, Silva, Diogo, Fernandes, Catarina, Faustino, Ricardo, Vasconcelos, Mónica, Pereira, Cristina, Costa, Carmen, Ribeiro, Joana Afonso, Amaral, Joana, Robalo, Conceição |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536233/ https://www.ncbi.nlm.nih.gov/pubmed/37781240 http://dx.doi.org/10.3389/fnins.2023.1259306 |
Ejemplares similares
-
Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex
por: Palavra, Filipe, et al.
Publicado: (2017) -
Monitoring and Managing Patients with Tuberous Sclerosis Complex: Current State of Knowledge
por: Gomes, Inês, et al.
Publicado: (2022) -
Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis
por: Rotstein, Dalia, et al.
Publicado: (2022) -
NEDA—NEutron Detector Array
por: Valiente-Dobón, J J, et al.
Publicado: (2019) -
No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
por: Pandit, Lekha
Publicado: (2019)